FdaApplication
NDA 208647
Identifiers
- fda_app_no: NDA208647
Properties
| Property | Value |
|---|---|
| applicant_name | SUN PHARMACEUTICAL INDUSTRIES LTD |
| application_type | NDA |
| approval_date | 2018-12-18 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EZALLOR SPRINKLE | ROSUVASTATIN CALCIUM | EQ 5MG BASE | CAPSULE;ORAL |
| EZALLOR SPRINKLE | ROSUVASTATIN CALCIUM | EQ 40MG BASE | CAPSULE;ORAL |
| EZALLOR SPRINKLE | ROSUVASTATIN CALCIUM | EQ 10MG BASE | CAPSULE;ORAL |
| EZALLOR SPRINKLE | ROSUVASTATIN CALCIUM | EQ 20MG BASE | CAPSULE;ORAL |
4 products